Literature DB >> 7957224

Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.

C B Brown1, C E Pihl, K Kaushansky.   

Abstract

The high-affinity granulocyte-macrophage-colony-stimulating-factor (GM-CSF) receptor (R) is composed of at least two subunits, termed alpha and beta. The alpha subunit is crucial for initiating ligand/receptor interaction and for ligand specificity. The experiments reported in this study sought to identify the domains of human (h)GM-CSF which are responsible for interaction with hGM-CSFR alpha. Anti-(human-GM-CSF) mAb were used as competitors in a 125I-GM-CSF receptor-binding assay on cells expressing the recombinant hGM-CSFR alpha chain. Inhibition of 125I-GM-CSF binding to the GM-CSFR alpha chain was demonstrated by mAb which mapped to the middle third of the third alpha helix (amino acids 78-83), the distal two-thirds of the third alpha helix and the initial 7 residues of the loop between the third and fourth helix (amino acids 78-94), and the extreme carboxy terminus. No inhibition of binding occured with an antibody whose domain begins in the first beta-pleated sheet (amino acids, 39-43), continues through the second helix (amino acids 55-64) and into the proximal third of the third helix (to amino acid 77). mAb which mapped to the distal half of the fourth helix and the carboxy-terminal tail (amino acids 110-127) increased the binding of 125I-GM-CSF to GM-CSFR alpha. Due to the known discontinous epitopes the possibility that the distal portion of the fourth helix contributes to binding cannot be eliminated. However, the domains of hGM-CSF most clearly involved in binding to the hGM-CSFR alpha are the distal two-thirds of the third alpha helix, the immediate downstream residues and the extreme carboxy terminus of hGM-CSF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957224     DOI: 10.1111/j.1432-1033.1994.0873b.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  Daniel H Doherty; Mary S Rosendahl; Darin J Smith; Jennifer M Hughes; Elizabeth A Chlipala; George N Cox
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

2.  SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.

Authors:  Markus D Lacher; Gerhard Bauer; Brian Fury; Sanne Graeve; Emily L Fledderman; Tye D Petrie; Dane P Coleal-Bergum; Tia Hackett; Nicholas H Perotti; Ying Y Kong; William W Kwok; Joseph P Wagner; Charles L Wiseman; William V Williams
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.